Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Chuck Ence

COO at Relmada Therapeutics, Inc. (RLMD)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+39.8%
vs. S&P 500+37.2%
Beat the market100%
Paper profit on buys+$162K
Total bought / sold$299K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Nov 6SEC RLMDRelmada Therapeutics, Inc. Buy 136,000403,931 held (+51%) $2.20 $299K +54.1%
  • Buy

    COO Chuck Ence bought $299K of RLMD at $2.20 — first open-market purchase in our records; raises the stake by 51%.